Concepedia
Statistics
Publications
65
Citations
3.2K
H-Index
32
Active since
1983
Affiliations
AstraZeneca (Sweden)(Current)
AstraZeneca (United Kingdom)
Sahlgrenska University Hospital
Uppsala University
AstraZeneca (United States)
Ulf G. Eriksson is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and clinical pharmacology.
Publications per year
1983–2021
The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic Effects
David Gustafsson, Jan-Erik Nyström, Stefan Carlsson et al. · Thrombosis Research · 2001 · 302 citations
Medicine, Pharmacokinetics, Pharmacology +17
Effects of Melagatran, a New Low-molecular-weight Thrombin Inhibitor, on Thrombin and Fibrinolytic Enzymes
Thomas Antonsson, Ulf G. Eriksson, Erika Gyzander et al. · Thrombosis and Haemostasis · 1998 · 209 citations
Medicine, Pharmacology, Pharmacotherapy +17
Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice.
A Miniscalco, Jonas Lundahl, C G Regårdh et al. · Journal of Pharmacology and Experimental Therapeutics · 1992 · 180 citations
Medicine, Medicinal Chemistry, Pharmacology +12
Absorption, Distribution, Metabolism, and Excretion of Ximelagatran, an Oral Direct Thrombin Inhibitor, in Rats, Dogs, and Humans
Ulf G. Eriksson, Ulf Bredberg, Kurt‐Jürgen Hoffmann et al. · Drug Metabolism and Disposition · 2003 · 155 citations
Pharmacy, Pharmacokinetics, Pharmacology +16
Pharmacokinetics and pharmacodynamics of ximelagatran, a novel oral direct thrombin inhibitor, in young healthy male subjects
Ulf G. Eriksson, Ulf Bredberg, Kristina Gislén et al. · European Journal of Clinical Pharmacology · 2003 · 138 citations
Medicine, Pharmacokinetics, Pharmacology +13
1–5 of 65